UMN Pharma Inc. reported non-consolidated earnings results for the quarter ended March 31, 2018. For the quarter, net sales were JPY 3,610,000 against JPY 2,943,000 a year ago. Operating loss was JPY 193,372,000 against JPY 141,129,000 a year ago. Ordinary loss was JPY 194,140,000 against profit of JPY 206,650,000 a year ago. Loss before income taxes was JPY 194,140,000 against profit of JPY 206,650,000 a year ago. Net loss was JPY 194,299,000 against profit of JPY 206,491,000 a year ago. Net loss per basic share was JPY 15.18 against income of JPY 16.94 a year ago.

For the fiscal year ending December 31, 2018, the company expects net sales to JPY 102 million, operating loss to be JPY 803 million, ordinary loss to be JPY 809 million, net loss to be JPY 810 million and loss per share to be JPY 63.31.